Degradation of 3-Hydroxy-3-methylglutaryl-CoA Reductase in Endoplasmic Reticulum Membranes Is Accelerated as a Result of Increased Susceptibility to Proteolysis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The endoplasmic reticulum (ER) membrane protein 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase is subject to regulated degradation when cells are presented with an excess of sterols or mevalonate. In this report, we demonstrate the degradation of HMG-CoA reductase in ER membranes prepared from cells which have been pretreated with mevalonate or sterols prior to membrane purification. Degradation of HMG-CoA reductase in membranes prepared from pretreated cells is more rapid than in membranes prepared from cells which have received no regulatory molecules. In vitro degradation is blocked by protease inhibitors previously shown to inhibit reductase degradation in vivo and is specific for intact HMG-CoA reductase. The lumenal contents of the ER membranes are dispensible for the regulated proteolysis and the proteases responsible for reductase degradation are stably associated with the ER membrane. Regulated proteolysis of HMG-CoA reductase is inhibited by lactacystin, a newly defined inhibitor of the multicatalytic protease, the proteasome, and in vitro degradation of reductase correlates with the presence of proteasome subunits in purified ER membranes. The ubiquitin system for protein degradation, which has recently been shown to be required for the degradation of several ER membrane proteins, is not required for the degradation of HMG-CoA reductase. Finally, we conclude that the regulated proteolysis of HMG-CoA reductase in response to regulatory molecules such as mevalonate or sterols is mediated by increased susceptibility of the reductase to ER proteases, rather than the induction of a new proteolytic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Cited by
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Oxysterols: Modulators of Cholesterol Metabolism and Other Processes
Schroepfer, G. J. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.1.361 · Cited by 973
Werner, E. D., Brodsky, J. L., & McCracken, A. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13797 · Cited by 462
Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway
Edwards, P. A., & Ericsson, J. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.157 · Cited by 458
ER-associated degradation in protein quality control and cellular regulation
Hampton, R. Y. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00358-7 · Cited by 415
Lactacystin, Proteasome Function, and Cell Fate
Fenteany, G., & Schreiber, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8545 · Cited by 410
DeBose-Boyd, R. A. (2008) · Cell Research · doi:10.1038/cr.2008.61 · Cited by 391
Bordallo, J., Plemper, R. K., Finger, A., & Wolf, D. H. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.1.209 · Cited by 374
Sever, N., Yang, T., Brown, M. S., Goldstein, J. L., & DeBose-Boyd, R. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00822-5 · Cited by 372
Rao, S., Porter, D. C., Chen, X., Herliczek, T., Lowe, M., & Keyomarsi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7797 · Cited by 345
ER protein quality control and proteasome-mediated protein degradation
Brodsky, J. L., & McCracken, A. A. (1999) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.1999.0321 · Cited by 344
Istvan, E. S., Palnitkar, M., Buchanan, S. K., & Deisenhofer, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.819 · Cited by 324
The Action of Molecular Chaperones in the Early Secretory Pathway
Fewell, S. W., Travers, K. J., Weissman, J. S., & Brodsky, J. L. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.090313 · Cited by 287
Brodsky, J. L., Werner, E. D., Dubas, M. E., Goeckeler, J. L., Kruse, K. B., & McCracken, A. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3453 · Cited by 287
Fisher, E. A., Zhou, M., Mitchell, D. M., Wu, X., Omura, S., Wang, H., Goldberg, A. L., & Ginsberg, H. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20427 · Cited by 286
Self-citationZhang, Y., Nijbroek, G., Sullivan, M. L., McCracken, A. A., Watkins, S. C., Michaelis, S., & Brodsky, J. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1303 · Cited by 277
Degradation of Connexin43 Gap Junctions Involves both the Proteasome and the Lysosome
Laing, J. G., Tadros, P. N., Westphale, E. M., & Beyer, E. C. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3747 · Cited by 252
Gereben, B., Goncalves, C., Harney, J. W., Larsen, P. R., & Bianco, A. C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0558 · Cited by 161
“Well known examples include cytosolic enzymes such as ornithine decarboxylase (1) and endoplasmic reticulum (ER) transmembrane protein hydroxy-methylglutaryl-coenzyme A reductase (2).”
Lange, Y., & Steck, T. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13103 · Cited by 105
Cholesterol-independent Effects of Statins and New Therapeutic Targets: Ischemic Stroke and Dementia
Miida, T., Hirayama, S., & Nakamura, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.253 · Cited by 97
Metadata
- Authors
- McGee, T. P., Cheng, H. H., Kumagai, H., Omura, S., & Simoni, R. D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-10
- Volume
- 271
- Issue
- 41
- Pages
- 25630-25638
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1992856659
- Cited by
- 103
- References
- 2
- FWCI
- 20.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.